PET-Based Radiogenomics Supports KEAP1/NFE2L2 Pathway Targeting for Non-Small Cell Lung Cancer Treated with Curative Radiotherapy

V. Bourbonne1,2, M. Morjani1, F. Lucia1,2, M. Hatt2, V. Jaouen2, S. Querellou3,4, D. Visvikis2, O. Pradier1,2, U. Schick1,2
1Radiation Oncology Department, Brest University Hospital, Brest, France
2LaTIM, INSERM, UMR 1101, University of Brest, ISBAM, UBO, UBL, Brest, France
3Nuclear Medicine Department, Brest University Hospital, Brest, France
4Groupe d'Étude de la Thrombose Occidentale GETBO (Inserm UMR 1304), University of Western Brittany, Brest, France